OPK Opko Health
- 1.195
- -0.035-2.85%
Opko Health News
Opko Health Buy Rating Backed by Strategic Asset Sale and Promising Oral Drug Candidate
OPKO Health Analyst Ratings
Critical Insights From OPKO Health Analyst Ratings: What You Need To Know
OPKO Health Analyst Ratings
Buy Rating Affirmed for Opko Health Amid Strategic Divestiture and Operational Improvement Prospects
Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Opko Health (OPK) and Leafly Holdings, Inc. (LFLY)
Barrington Cuts Price Target on OPKO Health to $1.50 From $2, Maintains Outperform Rating
Analysts Offer Insights on Healthcare Companies: Esperion (ESPR), Beam Therapeutics (BEAM) and Opko Health (OPK)
Optimistic Future Prospects and Financial Performance Bolster Buy Rating for Opko Health
Opko Health Maintains Buy Rating Amid Promising Q3 Results and Global Growth Hormone Expansion
Piper Sandler Sticks to Their Buy Rating for Opko Health (OPK)
Analysts Are Bullish on These Healthcare Stocks: Opko Health (OPK), Sagimet Biosciences, Inc. Class A (SGMT)
Analysts Offer Insights on Healthcare Companies: Opko Health (OPK) and BioNTech SE (BNTX)
HC Wainwright & Co. Reiterates Buy on OPKO Health, Maintains $3 Price Target
OPKO Health Analyst Ratings
Opko Health (OPK) Receives a Buy From H.C. Wainwright
Barrington Reaffirms Their Buy Rating on Opko Health (OPK)
Analysts Offer Insights on Healthcare Companies: Opko Health (OPK) and Simulations Plus (SLP)
Barrington Research Upgrades OPKO Health to Outperform, Announces $2 Price Target
HC Wainwright & Co. Reiterates Buy on OPKO Health, Maintains $3 Price Target
Analysis
Price Target
No Data
